APA (7th ed.) Citation

Völkers, M., Doroudgar, S., Nguyen, N., Konstandin, M. H., Quijada, P., Din, S., . . . Sussman, M. A. (2014). PRAS40 prevents development of diabetic cardiomyopathy and improves hepatic insulin sensitivity in obesity. EMBO molecular medicine, 6(1), . https://doi.org/10.1002/emmm.201303183

Chicago Style (17th ed.) Citation

Völkers, Mirko, et al. "PRAS40 Prevents Development of Diabetic Cardiomyopathy and Improves Hepatic Insulin Sensitivity in Obesity." EMBO Molecular Medicine 6, no. 1 (2014). https://doi.org/10.1002/emmm.201303183.

MLA (9th ed.) Citation

Völkers, Mirko, et al. "PRAS40 Prevents Development of Diabetic Cardiomyopathy and Improves Hepatic Insulin Sensitivity in Obesity." EMBO Molecular Medicine, vol. 6, no. 1, 2014, https://doi.org/10.1002/emmm.201303183.